434 related articles for article (PubMed ID: 23034169)
1. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
Yi H; Guo C; Yu X; Zuo D; Wang XY
J Immunol; 2012 Nov; 189(9):4295-304. PubMed ID: 23034169
[TBL] [Abstract][Full Text] [Related]
2. [Myeloid-derived Gr-1⁺ CD11b⁺ suppressor cells are involved in immunoregulation of experimental autoimmune encephalomyelitis].
Wu F; Dang D; Guo J; Li H; Yang K; Zhao D; Guo P; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):789-92, 797. PubMed ID: 25108427
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis.
Guo C; Hu F; Yi H; Feng Z; Li C; Shi L; Li Y; Liu H; Yu X; Wang H; Li J; Li Z; Wang XY
Ann Rheum Dis; 2016 Jan; 75(1):278-85. PubMed ID: 25371442
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells protect mouse models from autoimmune arthritis via controlling inflammatory response.
Zhang L; Zhang Z; Zhang H; Wu M; Wang Y
Inflammation; 2014 Jun; 37(3):670-7. PubMed ID: 24264477
[TBL] [Abstract][Full Text] [Related]
5. The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells.
Chung JS; Tamura K; Akiyoshi H; Cruz PD; Ariizumi K
J Immunol; 2014 Mar; 192(6):2576-84. PubMed ID: 24516197
[TBL] [Abstract][Full Text] [Related]
6. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
Glenn JD; Liu C; Whartenby KA
J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11b
Zhu J; Liu JQ; Liu Z; Wu L; Shi M; Zhang J; Davis JP; Bai XF
Front Immunol; 2018; 9():873. PubMed ID: 29740452
[TBL] [Abstract][Full Text] [Related]
8. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells.
McGinley AM; Sutton CE; Edwards SC; Leane CM; DeCourcey J; Teijeiro A; Hamilton JA; Boon L; Djouder N; Mills KHG
Immunity; 2020 Feb; 52(2):342-356.e6. PubMed ID: 32023490
[TBL] [Abstract][Full Text] [Related]
10. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
11. Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
Bravo B; Gallego MI; Flores AI; Bornstein R; Puente-Bedia A; Hernández J; de la Torre P; García-Zaragoza E; Perez-Tavarez R; Grande J; Ballester A; Ballester S
Stem Cell Res Ther; 2016 Mar; 7():43. PubMed ID: 26987803
[TBL] [Abstract][Full Text] [Related]
12. Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion.
Zhang G; Zhu X; Yang F; Li J; Leng X; Mo C; Li L; Wang Y
Pharm Biol; 2022 Dec; 60(1):899-908. PubMed ID: 36082828
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis.
Wang W; Jiao Z; Duan T; Liu M; Zhu B; Zhang Y; Xu Q; Wang R; Xiong Y; Xu H; Lu L
Eur J Immunol; 2015 Feb; 45(2):464-73. PubMed ID: 25352399
[TBL] [Abstract][Full Text] [Related]
14. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.
Alabanza LM; Esmon NL; Esmon CT; Bynoe MS
J Immunol; 2013 Oct; 191(7):3764-77. PubMed ID: 23997223
[TBL] [Abstract][Full Text] [Related]
16. IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells.
Yu P; Bamford RN; Waldmann TA
Eur J Immunol; 2014 Nov; 44(11):3330-41. PubMed ID: 25142300
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome Proliferator-Activated Receptor-δ Acts within Peripheral Myeloid Cells to Limit Th Cell Priming during Experimental Autoimmune Encephalomyelitis.
Drohomyrecky PC; Doroshenko ER; Akkermann R; Moshkova M; Yi TJ; Zhao FL; Ahn JJ; McGaha TL; Pahan K; Dunn SE
J Immunol; 2019 Nov; 203(10):2588-2601. PubMed ID: 31578267
[TBL] [Abstract][Full Text] [Related]
18. The NF-κB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis.
Chen G; Hardy K; Pagler E; Ma L; Lee S; Gerondakis S; Daley S; Shannon MF
J Immunol; 2011 Nov; 187(9):4483-91. PubMed ID: 21940679
[TBL] [Abstract][Full Text] [Related]
19. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin I2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalomyelitis.
Zhou W; Dowell DR; Huckabee MM; Newcomb DC; Boswell MG; Goleniewska K; Lotz MT; Toki S; Yin H; Yao S; Natarajan C; Wu P; Sriram S; Breyer RM; Fitzgerald GA; Peebles RS
PLoS One; 2012; 7(5):e33518. PubMed ID: 22590492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
